Imunohemija - CLIA (hemiluminiscenca): Reagensi
Frontiers | Cross Talk Between Macrophages and Cancer Cells in the Bone Metastatic Environment | Endocrinology
Osteosarkom – MladiCe Srbije
Tumor markeri - Tumor
Mišićno koštani tumori
Spatiotemporal PET Imaging Reveals Differences in CAR-T Tumor Retention in Triple-Negative Breast Cancer Models: Molecular Therapy
Mišićno koštani tumori
Osteoporoza - Aqualab
Tumor marker CEA i CA 19-9, šta su i da li su 100 % sigurni?
A new insight on serum microRNA expression as novel biomarkers in breast cancer patients - Bahmanpour - 2019 - Journal of Cellular Physiology - Wiley Online Library
Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle | Nature Medicine
The Pipette Gazette » In Press: Adam Kosti Publishes First Author Paper
Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors - ScienceDirect
Uloga tumor markera - Tumor
Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer | PNAS
Šta su tumorski markeri? Nedostaci tumor markera | Kancer
Najčešće korišćeni tumor markeri. - Tumor
Targeting PVR (CD155) and its receptors in anti-tumor therapy | Cellular & Molecular Immunology
SERBP1 affects cancer-related phenotypes and tumor growth. a Knockdown... | Download Scientific Diagram
Born to survive: how cancer cells resist CAR T cell therapy | Journal of Hematology & Oncology | Full Text
Tumor markeri
Frontiers | Immune Microenvironment of Brain Metastases—Are Microglia and Other Brain Macrophages Little Helpers? | Immunology
Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas
MicroRNA replacement therapy in cancer - Mollaei - 2019 - Journal of Cellular Physiology - Wiley Online Library
Maligni tumori kostiju - Tumor
